2.0
May 13, 2026
Current employee, more than 5 years
Recommend
CEO approval
Business Outlook
Pros
Everyone cares about the mission of cancer research and treatment.
Cons
Management is not transparent at all. They say one thing and do another and seem to be winging it. Rolling RIFs for years now feels like psychological warfare. The c-suite prefers to decimate DigITs' individual contributors than hold middle managers accountable for overspending. A lot of painful heavy lifting is invisible to higher management. Unclear promotion paths and career development opportunities except for a minority of highly vocal super heroes. MSK's mission and values are frequently undermined by middle management.